Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Gillessen S, Murphy L, James ND, Sachdeva A, El-Taji O, Abdel-Aty H, Adler AI, Amos C, Attard G, Varughese M, Gale J, Brown S, Srihari N, Birtle AJ, Brown M, Chan K, Chowdhury S, Cross W, Dearnaley DP, Din O, Dutey-Magni P, Gilbert DC, Gilson C, Gray S, Grist E, Hofmann U, Hudson AM, Jain Y, Jeyasangar G, Jones R, Kayani M, Langley RE, Malik Z, Mason MD, Matheson D, McAlpine C, Macnair A, Millman R, Murphy C, Padden-Modi M, Parikh O, Parker C, Rush H, Russell M, Srinivasan R, Sundar S, Tanguay JS, Turco F, Williams P, Sydes MR, Parmar MKB, Brown LC, Clarke NW; STAMPEDE investigators. Gillessen S, et al. Lancet Oncol. 2025 Aug;26(8):1018-1030. doi: 10.1016/S1470-2045(25)00231-1. Epub 2025 Jul 7. Lancet Oncol. 2025. PMID: 40639383 Free PMC article. Clinical Trial.
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Leone G, Orlando F, Dutey-Magni P, Vainauskas O, Grist E, Ciani Y, Lall S, Thakali S, Wingate A, Wetterskog D, Sachdeva A, Sydes MR, McPhail N, Sreenivasan T, O'Sullivan JM, Clarke NW, Parmar MKB, Brown LC, James ND, Demichelis F, Attard G; STAMPEDE collaborators. Leone G, et al. JAMA Oncol. 2025 Feb 27;11(4):426-9. doi: 10.1001/jamaoncol.2024.7051. Online ahead of print. JAMA Oncol. 2025. PMID: 40014335
Apparent diffusion coefficient as a quantitative biomarker for prostate cancer treatment response on a 1.5 Tesla magnetic resonance-linear accelerator: Impact of image registration and acquisition type.
Nair PP, Chick J, Nuixe M, Lecoeur B, Xiao Y, Cooper S, Tree AC, van Houdt PJ, Oelfke U, Wetscherek A. Nair PP, et al. Among authors: tree ac. Phys Imaging Radiat Oncol. 2025 Oct 13;36:100851. doi: 10.1016/j.phro.2025.100851. eCollection 2025 Oct. Phys Imaging Radiat Oncol. 2025. PMID: 41146990 Free PMC article.
Exploring Factors Associated with Late Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: Findings from the PACE-B Study.
Ratnakumaran R, Brand DH, Sasitharan A, Mohajer J, Hinder V, Khan A, Mayet H, Loblaw A, Hall E, van As N, Tree AC; PACE Trial Investigators. Ratnakumaran R, et al. Among authors: tree ac. Eur Urol. 2025 Oct 22:S0302-2838(25)00397-5. doi: 10.1016/j.eururo.2025.07.007. Online ahead of print. Eur Urol. 2025. PMID: 41130825 Free article.
Pelvic stereotactic ablative body radiotherapy (SABR) reirradiation: UK SABR consortium guidance for use in routine clinical care.
Moreno-Olmedo E, Owczarczyk K, Chadwick E, Dickinson P, Duffton A, Jones B, Good JS, McDonald F, Murray LJ, Rackley T, Robinson M, Sinclair J, Strawson-Smith T, Tree A, Tsang YM, Zarkar A, Dean C, Díez P, Williams M, Andratschke N, Muirhead R. Moreno-Olmedo E, et al. Among authors: tree a. Tech Innov Patient Support Radiat Oncol. 2025 Aug 5;35:100326. doi: 10.1016/j.tipsro.2025.100326. eCollection 2025 Sep. Tech Innov Patient Support Radiat Oncol. 2025. PMID: 40822090 Free PMC article.
Harnessing Radiation Biology to Increase Cancer Cure Rates.
Harrington KJ, Veerapathiran S, Tree AC. Harrington KJ, et al. Among authors: tree ac. Cancer J. 2025 Jul-Aug 01;31(4):e0783. doi: 10.1097/PPO.0000000000000783. Epub 2025 Aug 11. Cancer J. 2025. PMID: 40768304 No abstract available.
194 results